Perhaps the mitigation of fatty liver in this model reflects both diminished lipid mobilization from adipocytes to ectopic sites as well as enhanced hepatic lipid metabolism driven by hepatic (and possibly extra-hepatic) amplification of NRF2 signaling. Here, NFE2L2 is linked to fatty liver disease.